Variables | Young Group | Control Group | P |
Age (Mean) | 32.94 | 52.00 | |
Gender | <0.001 | ||
Female, n (%) | 29 (52.73) | 13 (20.97) | |
Male, n (%) | 26 (47.27) | 49 (79.03) | |
Female:Male | 1.12:1 | 0.27:1 | |
Tumor Location, n (%) | 0.001 | ||
Upper 1/3 | 2 (3.64) | 18 (29.03) | |
Middle 1/3 | 15 (27.27) | 19 (30.65) | |
Lower 1/3 | 31 (56.36) | 20 (32.26) | |
≥Two Thirds | 7 (12.73) | 5 (8.06) | |
Tumor Size, n (%) | 0.004 | ||
≤4 cm | 8 (14.55) | 25 (40.32) | |
>4 cm | 47 (85.45) | 37 (59.68) | |
Macroscopic Type, n (%) | 0.001 | ||
Borrmann I | 2 (3.64) | 17 (27.42) | |
Borrmann II | 18 (32.73) | 24 (38.71) | |
Borrmann III | 32 (58.18) | 20 (32.26) | |
Borrmann IV | 3 (5.45) | 1 (1.61) | |
Histological Type, n (%) | 0.039 | ||
Poorly Differentiated | 45 (81.82) | 39 (62.90) | |
Well-Differentiated | 10 (18.18) | 23 (37.10) | |
The 7th T Stage (UICC), n (%) | 0.025 | ||
T1 + T2 | 10 (18.18) | 24 (38.71) | |
T3 + T4 | 45 (81.82) | 38 (61.29) | |
Lymph Node Involvement, n (%) | 0.063 | ||
N0 | 8 (14.55) | 21 (33.87) | |
N1 | 10 (18.18) | 13 (20.97) | |
N2 | 32 (58.18) | 23 (37.10) | |
N3 | 5 (9.09) | 5 (8.06) | |
TNM Stage, n (%) | <0.001 | ||
I | 4 (7.27) | 11 (17.74) | |
II | 5 (9.09) | 14 (22.58) | |
III | 9 (16.36) | 27 (43.55) | |
IV | 37 (67.27) | 10 (16.13) | |
Surgical Radicalism, n (%) | <0.001 | ||
Curative Resection | 31 (56.36) | 46 (74.19) | |
Palliative Resection | 5 (9.09) | 13 (20.97) | |
Exploratory Laparoscopy | 19 (34.55) | 3 (4.84) | |
Adjuvant Chemotherapy, n (%) | 0.063 | ||
Yes | 27 (49.10) | 42 (67.74) | |
No | 28 (50.90) | 20 (32.26) |